In children with asthma, is excess weight linked to dysanapsis and PAI — and how do all 3 factors affect the risk of uncontrolled asthma?
All articles by Virginia A. Schad, PharmD, RPh
Research presented at ACAAI 2021 evaluated the efficacy of different biologic therapies in controlling asthma exacerbations in patients with varying BECs.
CHRONICLE investigators reported results of a patient survey on common asthma triggers at ACAAI 2021.
The SINUS-24/52 trial evaluated dupilumab’s impact on CRSwNP and comorbid asthma, looking at baseline asthma characteristics.
In CHRONICLE, researchers examined associations between exacerbations and initiation of biologic therapy in patients with uncontrolled severe asthma.
Is asthma triple therapy with umeclidinium plus fluticasone furoate/vilanterol effective for patients with uncontrolled asthma who overuse SABA as rescue therapy?
Which therapy more effectively reduces severe COPD exacerbations: once-daily FF/UMEC/VI or twice-daily ICS/LABA?
To what extent does hospital fluid culture influence the mortality rates of patients with severe sepsis and septic shock?
With cannabis use on the rise, what do we know about patients with asthma who use cannabis?
Asthma and chronic obstructive pulmonary disease (COPD) do not appear to increase the risk of mortality in patients with COVID-19.
Latest News Your top articles for FridayFor More Personalized News
Haymarket Medical NetworkTop Picks
Continuing Medical Education (CME/CE) Courses